Trials / Completed
CompletedNCT03457883
Risk Factors for Recurrence After Pelvic Reconstruction
Risk Factors for Recurrence After Pelvic Reconstruction of Pelvic Organ Prolapse:1 Year Follow-up in Patients Implanted Hernia Mesh and Biological Graft
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 232 (actual)
- Sponsor
- Nanjing Medical University · Academic / Other
- Sex
- Female
- Age
- 52 Years – 76 Years
- Healthy volunteers
- Not accepted
Summary
232 women underwent transvaginal mesh repair (TVM)with /without transvaginal hysterectomy for symptomatic POP, including group A(accepted herniamesh polypropylene mesh, 117 patients);group B (underwent biological graft of cook,115 patients);follow-ups for six months and one year after the surgery and a questionnaire about the life habits associated with relapse.
Detailed description
We prospectively study a total of 232 women who underwent transvaginal mesh repair (TVM)with /without transvaginal hysterectomy for symptomatic POP, the patients into two groups :group A was accepted herniamesh polypropylene mesh(117);group B underwent biological graft of cook(115);Each patient underwent an interview that included a POP-Q which was quantified according to the Pelvic Organ Prolapse Quantitation (POPQ) system;follow-ups for six months and one year after the surgery and a questionnaire about the life habits associated with relapse.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | herniamesh | Patients were randomly assigned in a ratio of 1:1,by using SPSS19.0 statistical software, to either trocar-guided transvaginal mesh(herniamesh, group A) or biological graft (cook, group B)repair. |
| DEVICE | biological graft | Patients were randomly assigned in a ratio of 1:1,by using SPSS19.0 statistical software, to either trocar-guided transvaginal mesh(herniamesh, group A) or biological graft (cook, group B)repair. |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2016-06-01
- Completion
- 2017-12-01
- First posted
- 2018-03-08
- Last updated
- 2018-03-08
Source: ClinicalTrials.gov record NCT03457883. Inclusion in this directory is not an endorsement.